Your browser doesn't support javascript.
loading
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.
Wang, Guocan; Lu, Xin; Dey, Prasenjit; Deng, Pingna; Wu, Chia Chin; Jiang, Shan; Fang, Zhuangna; Zhao, Kun; Konaparthi, Ramakrishna; Hua, Sujun; Zhang, Jianhua; Li-Ning-Tapia, Elsa M; Kapoor, Avnish; Wu, Chang-Jiun; Patel, Neelay Bhaskar; Guo, Zhenglin; Ramamoorthy, Vandhana; Tieu, Trang N; Heffernan, Tim; Zhao, Di; Shang, Xiaoying; Khadka, Sunada; Hou, Pingping; Hu, Baoli; Jin, Eun-Jung; Yao, Wantong; Pan, Xiaolu; Ding, Zhihu; Shi, Yanxia; Li, Liren; Chang, Qing; Troncoso, Patricia; Logothetis, Christopher J; McArthur, Mark J; Chin, Lynda; Wang, Y Alan; DePinho, Ronald A.
Afiliação
  • Wang G; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lu X; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dey P; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Deng P; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wu CC; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jiang S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fang Z; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Zhao K; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Konaparthi R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hua S; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Li-Ning-Tapia EM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kapoor A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wu CJ; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel NB; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Guo Z; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ramamoorthy V; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tieu TN; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Heffernan T; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhao D; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shang X; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Khadka S; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hou P; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hu B; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jin EJ; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Biological Science, College of Natural Sciences, Wonkwang University, Cheonbuk, Iksan, South Korea.
  • Yao W; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pan X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ding Z; Sanofi Oncology, Cambridge, Massachusetts.
  • Shi Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Li L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Chang Q; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Troncoso P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Logothetis CJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • McArthur MJ; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chin L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang YA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. yalanwang@mdanderson.org rdepinho@mdanderson.org.
  • DePinho RA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. yalanwang@mdanderson.org rdepinho@mdanderson.org.
Cancer Discov ; 6(1): 80-95, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26701088
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Células Mieloides / PTEN Fosfo-Hidrolase / Proteína Smad4 / Quimiocina CXCL5 Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Cancer Discov Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Células Mieloides / PTEN Fosfo-Hidrolase / Proteína Smad4 / Quimiocina CXCL5 Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Cancer Discov Ano de publicação: 2016 Tipo de documento: Article